[Atypical celiac disease in a patient with type 1 diabetes mellitus and Hashimoto's thyreoiditis].

[Atypical celiac disease in a patient with type 1 diabetes mellitus and Hashimoto's thyreoiditis]. Dtsch Med Wochenschr (2011) 0.75

Celiac disease with cerebral and peripheral nerve involvement mimicking multiple sclerosis. J Med Life (2014) 0.75

Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus. Gut (2008) 2.93

Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology (2000) 2.66

Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's oesophagus. Gut (2008) 2.20

Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus. Endoscopy (2010) 2.11

Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol (2000) 2.03

Curative endoscopic therapy in patients with early esophageal squamous-cell carcinoma or high-grade intraepithelial neoplasia. Endoscopy (2007) 1.94

Ablation of Barrett's epithelium by endoscopic argon plasma coagulation in combination with high-dose omeprazole. Gastrointest Endosc (2000) 1.94

Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther (2003) 1.91

In vivo diagnosis of collagenous colitis by confocal endomicroscopy. Gut (2006) 1.82

Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76

[German S3-guideline "Diagnosis and treatment of esophagogastric cancer"]. Z Gastroenterol (2011) 1.74

OLGA staging for gastritis: a tutorial. Dig Liver Dis (2008) 1.64

Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut (2004) 1.62

Long-term clinical course of extra-oesophageal manifestations in patients with gastro-oesophageal reflux disease. A prospective follow-up analysis based on the ProGERD study. Dig Liver Dis (2006) 1.57

European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis (2013) 1.53

Comparison of methylene blue-directed biopsies and four-quadrant biopsies in the detection of high-grade intraepithelial neoplasia and early cancer in Barrett's oesophagus. Dig Liver Dis (2006) 1.53

Valid symptom reporting at upper endoscopy in a random sample of the Swedish adult general population: the Kalixanda study. Scand J Gastroenterol (2004) 1.49

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47

European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44

Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther (2003) 1.40

[Remove polyps and discard. Way or wrong way?]. Pathologe (2015) 1.39

[The status of diagnosis of Barrett esophagus. An analysis of 1000 histologically diagnosed cases]. Dtsch Med Wochenschr (1997) 1.39

Confocal laser endomicroscopy: technical status and current indications. Endoscopy (2006) 1.36

S3-guideline "helicobacter pylori and gastroduodenal ulcer disease" of the German society for digestive and metabolic diseases (DGVS) in cooperation with the German society for hygiene and microbiology, society for pediatric gastroenterology and nutrition e. V., German society for rheumatology, AWMF-registration-no. 021 / 001. Z Gastroenterol (2009) 1.27

Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis. Endoscopy (2007) 1.27

Methylation of SOCS-3 and SOCS-1 in the carcinogenesis of Barrett's adenocarcinoma. Gut (2007) 1.22

Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): curative treatment using local endoscopic treatment techniques. Endoscopy (2002) 1.20

HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer (2009) 1.17

In-vivo confocal real-time mini-microscopy in animal models of human inflammatory and neoplastic diseases. Endoscopy (2007) 1.17

Specific detection and prevalence of Helicobacter heilmannii-like organisms in the human gastric mucosa by fluorescent in situ hybridization and partial 16S ribosomal DNA sequencing. J Clin Microbiol (2001) 1.15

Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus. Endoscopy (2012) 1.11

Confocal laser scanning fluorescence microscopy for in vivo determination of microvessel density in Barrett's esophagus. Endoscopy (2008) 1.09

Report of an Amsterdam working group on Barrett esophagus. Virchows Arch (2003) 1.08

Review article: in vivo imaging by endocytoscopy. Aliment Pharmacol Ther (2011) 1.06

Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study. Gut (2005) 1.04

Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions. Endoscopy (2007) 1.00

Fundic gland polyps (Elster's cysts) of the gastric mucosa. A marker for colorectal epithelial neoplasia? Pathol Res Pract (2002) 1.00

Differential expression of mucins and trefoil peptides in native epithelium, Barrett's metaplasia and squamous cell carcinoma of the oesophagus. J Cancer Res Clin Oncol (1999) 0.99

[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"]. Z Gastroenterol (2009) 0.96

Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy. Dig Dis (2004) 0.96

In-vivo microvascular imaging of early squamous-cell cancer of the esophagus by confocal laser endomicroscopy. Endoscopy (2007) 0.94

Predicting leucine zipper structures from sequence. Protein Eng (1996) 0.94

Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression. Br J Cancer (2009) 0.94

Biliary pneumonitis after proximal stent migration. Gastrointest Endosc (2001) 0.93

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Quality assurance in pathology in colorectal cancer screening and diagnosis. Endoscopy (2012) 0.93

Mixed adenoneuroendocrine carcinoma (MANEC) of the esophagogastric junction predominantly consisting of poorly differentiated neuroendocrine carcinoma. Endoscopy (2013) 0.91

Epithelial cells disseminate into the bone marrow of colorectal adenoma patients. Gut (2005) 0.91

Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD study. Aliment Pharmacol Ther (2009) 0.91

Circumferential and axial distribution of esophageal mucosal damage in reflux disease. Dis Esophagus (2007) 0.91

[Gastric metastasis from small cell lung cancer]. Pneumologie (2009) 0.90

First description of eosinophilic esophagitis using confocal laser endomicroscopy (with video). Endoscopy (2011) 0.90

A double-blind dose-escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis. Aliment Pharmacol Ther (2005) 0.89

[Plexiform angiomyxoid myofibroblastic tumour of the stomach]. Pathologe (2012) 0.87

Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer. Br J Cancer (2011) 0.86

Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther (2008) 0.86

The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Hum Pathol (1999) 0.85

Interleukin-7 enhances antimicrobial activity against Leishmania major in murine macrophages. Infect Immun (1993) 0.85

Down-regulation of Akt/PKB in senescent cardiac fibroblasts impairs PDGF-induced cell proliferation. Cardiovasc Res (2001) 0.84

[Histopathological diagnosis of Barrett's mucosa and associated neoplasias. Results of a consensus conference of the Working Group for "Gastroenterological Pathology of the German Society for Pathology" on 22 September 2001]. Pathologe (2003) 0.83

Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus. Endoscopy (2005) 0.83

Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis. Br J Cancer (2013) 0.83

Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis. Immunology (1995) 0.83

Early stage adenocarcinoma of the esophagus arising in circular heterotopic gastric mucosa treated by endoscopic mucosal resection. Gastrointest Endosc (2001) 0.83

Paracetamol-induced perforation of the esophagus in a patient with eosinophilic esophagitis. Endoscopy (2010) 0.82

The effect of single-dose naproxen on eicosanoid formation in human gastroduodenal mucosa. Aliment Pharmacol Ther (2006) 0.82

[Lymph node metastasis in superficial squamous carcinoma of the esophagus]. Pathologe (2013) 0.82

Multifocal early gastric cancer in a patient with autoimmune atrophic gastritis and iron deficiency anaemia. Z Gastroenterol (2009) 0.82

[Histopathological diagnosis and differential diagnosis of colorectal serrated polys: findings of a consensus conference of the working group "gastroenterological pathology of the German Society of Pathology"]. Pathologe (2011) 0.82

[Granular cell tumor of the stomach]. Pathologe (2012) 0.81

[Risk factors for lymphatic metastasis from pT1 colorectal adenocarcinoma]. Pathologe (2003) 0.80

Confocal laser endomicroscopy for the in vivo detection of intraepithelial neoplasia in Peutz-Jeghers polyps. Endoscopy (2010) 0.80

Combined use of narrow-band imaging magnification endoscopy and miniprobe confocal laser microscopy in neoplastic Barrett's esophagus. Endoscopy (2007) 0.80

[The quality of quality indicators: Comments on the preliminary report "Sector-crossing quality assurance in the health service - colorectal cancer" of AQUA - Institute for Applied Quality Promotion and Research in Health Services]. Zentralbl Chir (2011) 0.80

Editorial: Defining a bad Barrett's segment: is it dependent on goblet cells? Am J Gastroenterol (2009) 0.79

Effects of long-term treatment with proton pump inhibitors in gastro-oesophageal reflux disease on the histological findings in the lower oesophagus. Scand J Gastroenterol (2000) 0.79

The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol (2001) 0.79

Genome wide array comparative genomic hybridisation analysis of premalignant lesions of the stomach. Mol Pathol (2003) 0.79

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]. Z Gastroenterol (2016) 0.79

[Hereditary gastric cancer]. Pathologe (2010) 0.78

Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Contra. Endoscopy (2007) 0.78

Real-time in vivo histologic examination using a probe-based endocytoscopy system for differentiating duodenal polyps. Endoscopy (2013) 0.78

Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance. Aliment Pharmacol Ther (2003) 0.78

[Tubular adenoma of the stomach with special reference to the Japanese criteria and pyloric gland adenoma]. Pathologe (2010) 0.77

[Extensive squamous papillomatosis of the oesophagus with malignant transformation of squamous epithelium]. Z Gastroenterol (2011) 0.77

Dramatic increase of alpha-hydroxyaldehydes derived from plasmalogens in the aged human brain. Chem Phys Lipids (1997) 0.77

Fluorescein-aided endomicroscopy for detection of signet ring cell carcinoma. Endoscopy (2011) 0.77

Short Barrett: prevalence and risk factors. Scand J Gastroenterol (1999) 0.77

Critical reappraisal of current surveillance strategies for Barrett's esophagus: analysis of a large German Barrett's database. Dis Esophagus (2008) 0.77

High-definition endoscopy with i-scan enables diagnosis of characteristic mucosal lesions in Whipple's disease. Endoscopy (2012) 0.77

[S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease]. Z Gastroenterol (2016) 0.77

Gastritis and gastric cancer: which morphological type of Helicobacter gastritis is a precancerous risk? Chin J Dig Dis (2005) 0.76

[Barrett's esophagus: analyses from human and experimental animal studies]. Pathologe (2013) 0.76

Re: Richter et al.: possibly protective properties of Helicobacter pylori in connection with GERD. Am J Gastroenterol (1999) 0.76

Advanced endoscopic imaging using narrow-band imaging for diagnosis of Whipple's disease. Endoscopy (2012) 0.76

Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care--a 5-year follow-up. Aliment Pharmacol Ther (2009) 0.76

Bloody diarrhea caused by enterohemorrhagic Escherichia coli (EHEC). Endoscopy (2011) 0.76

Endoscopic mucosal resection and the risk of lymph-node metastases: indications revisited? Endoscopy (2006) 0.76

Markers of tumour angiogenesis and tumour cells in bone marrow in gastric cancer patients. Eur J Surg Oncol (2007) 0.76

Persistent dysplasia within long-segment Barrett's esophagus in a patient with Gardner's syndrome. Endoscopy (2005) 0.75

Simultaneous detection and differentiation of anti-Helicobacter pylori antibodies by flow microparticle immunofluorescence assay. Clin Diagn Lab Immunol (2004) 0.75